Executive Profile

Robert L. Zerbe M.D. Co-Founder, Chief Executive Officer, President and Director, QuatRx Pharmaceuticals Company

Age	Total Calculated Compensation	This person is connected to 7 Board Members in 7 different organizations across 9 different industries. See Board Relationships
61	--

Background

Dr. Robert L. Zerbe, M.D., Co-Founded QUATRx Pharmaceuticals Company in 2000 and has been its Chief Executive Officer and President since November 2000. Dr. Zerbe has more than 25 years of pharmaceutical development experience including general management, global clinical research and development, clinical trial design and management, and regulatory affairs. From 1982 to 2000, Dr. Zerbe held a variety of research and development positions. During 2000, he served as Senior ... Vice President of Global Research and Development and Director of Development Operations at Pfizer Inc. From 1993 to 2000, Dr. Zerbe served as Senior Vice President of Worldwide Clinical Research and Development at the Parke-Davis Pharmaceutical Research Division of the Warner-Lambert Company and oversaw the successful development programs for Lipitor, Neurontin and other key products. From 1982 to 1993, he held a variety of positions of increasing responsibility at Eli Lilly & Company, Inc. including Managing Director of Lilly Research Center U.K. and Vice President of Clinical Investigation and Regulatory Affairs. He has been the Chairman of Aastrom Biosciences, Inc. since October 2012. He has been a Director at Optimer Pharmaceuticals, Inc. since December 3, 2009 and Metabolex, Inc. since September 30, 2008; QUATRx Pharmaceuticals since November 2000; Lundbeck Research USA, Inc. since February, 2002 and Aastrom Biosciences Inc since January 2006. He serves as a Member of the Board of Directors at Edgemont Pharmaceuticals, LLC. Dr. Zerbe serves as a Member of Scientific and Clinical Advisory Board of OncoMed Pharmaceuticals Inc. and Director of Biotechnology Industry Organization Emerging Section Governing Body. He served as a Director of AP Pharma Inc. from December 2002 to April 18, 2011. He served as a Director of Maxim Pharmaceuticals Inc. since 2002; Corgentech Inc. since November 2005 and Anesiva, Inc. from November 2005 to December 16, 2008. Dr. Zerbe earned his Medical Degree at Indiana University in 1975 and did Post-graduate Training in Internal Medicine, Endocrinology and Neuroendocrinology at Indiana University and the National Institutes of Mental Health.

Corporate Headquarters 777 East Eisenhower Parkway Ann Arbor, Michigan 48108 United States Phone: 734-913-9900 Fax: 734-913-0743 Board Members Memberships Member of The Board of Directors Edgemont Pharmaceuticals, LLC 2000-Present Co-Founder, Chief Executive Officer, President and Director QuatRx Pharmaceuticals Company 2002-2011 Former Director, Member of Nominating & Governance Committee and Member of Audit & Finance Committee AP Pharma Inc. 2002-N/A Former Director and Chairman of Governance & Nominating Committee Maxim Pharmaceuticals Inc. 2002-Present Director Lundbeck Research USA, Inc. 2005-N/A Former Director Corgentech Inc. 2005-2008 Former Director and Member of Compensation Committee Anesiva, Inc. 2006-Present Chairman of the Board, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee Aastrom Biosciences, Inc. 2008-Present Director Metabolex, Inc. 2009-Present Director, Member of Audit Committee and Member of Compensation, Nominating & Corporate Governance Committee Optimer Pharmaceuticals, Inc. Education BA Indiana University, Bloomington Master's Degree Indiana University, Bloomington Other Affiliations Aastrom Biosciences, Inc. AP Pharma Inc. Maxim Pharmaceuticals Inc. Metabolex, Inc. Lundbeck Research USA, Inc. Pfizer Inc. Corgentech Inc. Anesiva, Inc. Optimer Pharmaceuticals, Inc. Indiana University, Bloomington Indiana University School of Medicine OncoMed Pharmaceuticals, Inc. National Institute Of Mental Health Edgemont Pharmaceuticals, LLC

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.